Poster Presentation at NATSJ 2026

DLeader presented a poster at the 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held from July 7–9, 2026 at Dejima Messe Nagasaki. The presentation introduced DLeader’s Agentic AI approach to nucleic acid drug discovery, including ASO design, candidate evaluation and prioritization, and decision-making support for early-stage RNA therapeutic development. Through discussions with researchers and industry participants, DLeader exchanged perspectives on the application of AI to nucleic acid therapeutics and explored opportunities for further collaboration.